AOD-9604 research guide

AOD-9604 in China — Sourcing Guide

Research-grade AOD-9604 sourcing guide for China. COA verification, vendor selection, and handling protocols.

Browse Regions Order AOD-9604 →

Navigating AOD-9604 Access in China

Research-grade AOD-9604 is sourced by China researchers overwhelmingly via international research vendors — the domestic retail market for research compounds is effectively nonexistent in China to products without meaningful analytical verification. The practical sourcing landscape for China researchers is served almost exclusively by international vendors, primarily based in the US, EU, and China — with a wide quality spectrum from top-tier to low-grade. For China researchers, the most important skill is checking analytical documentation without relying on third parties rather than depending on domestic consumer protection frameworks. Use this guide to navigate AOD-9604 sourcing in China — combining the analytical standards with China import and shipping knowledge.

The Science Behind AOD-9604

Growth hormone secretagogue research has significant overlap with sports science, endocrinology, and aging research — three well-funded academic areas where China may have established infrastructure. The GH-IGF-1 axis is a central pathway in both muscle biology and aging, and research using compounds like AOD-9604 to probe this pathway can connect to existing departmental expertise and animal model infrastructure. China researchers with access to endocrinology or sports science departments may find collaborative opportunities that accelerate both the establishment of appropriate animal models and the interpretation of hormonal outcome data.

Order AOD-9604 in China
COA-verified · Ships to China · International tracking
Order Now →

Browse by Region

Top Cities in China

Finding Quality AOD-9604 in China

Pricing benchmarks help China researchers determine whether pricing reflects quality or trade-offs — standard research-grade AOD-9604 should be priced within a reasonable range of similar vendors, and significantly below-market pricing almost always signals compromises. The COA verification step that China researchers frequently overlook is checking that the certificate batch reference matches the actual vial you receive — a COA is only meaningful when it is specific to the exact lot in hand. Express shipping options from most major vendors reduce delivery timelines to 3-7 days — the main unpredictable variable is customs handling time, typically contributing an additional 2 to 5 working days. The community research step is often underweighted by new buyers — it is the most valuable step before any AOD-9604 purchase for China researchers.

AOD-9604 Protocols & Precautions

The most significant quality-related safety concern for AOD-9604 is endotoxin from inadequate quality control — verify endotoxin testing is included in your batch COA ahead of any protocol involving administration. Proper handling of AOD-9604 once reconstituted: swab the vial septum with an alcohol prep pad before each withdrawal, use a fresh needle for each draw, and dispose of any reconstituted AOD-9604 that looks cloudy or shows visible particles. For institutional researchers in China: your institution's institutional biosafety and compliance functions have relevant oversight over research compound use and should be consulted before beginning any formal protocol.

Order AOD-9604 — ships to China
COA-verified · International shipping · All compounds research grade
Order Now →

Frequently Asked Questions

What is AOD-9604?

AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.

How does AOD-9604 differ from growth hormone?

AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.

What is the clinical trial history of AOD-9604?

AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.